Sanofi, Pan-Canadian Pharmaceutical Alliance Sign Letter Of Intent For Sarclisa
Benzinga Newsdesk 10 hours ago
NewsFDA
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Agreement paves the way for newly diagnosed, transplant-ineligible patients fighting multiple myeloma to access first-line treatment Sarclisa® through provincial and territorial cancer treatment formulary listings.
